Techno Trends
The most recent inventions, innovations, and ground-breaking technologies that are revolutionizing the healthcare landscape are presented to you in this section.
FDA Grants Breakthrough Status to ICU Medical’s Plum Solo™ and Plum Duo™ Precision IV Pumps
ICU Medical Inc has received 510(k) clearance from the U.S. Food and Drug Administration for its new Plum Solo™ precision IV pump. This single-channel pump complements the previously cleared dual-channel Plum Duo...
Alpha Cognition Launches Breakthrough ZUNVEYL for Mild to Moderate Alzheimer’s
Alpha Cognition, a biopharmaceutical company focused on neurodegenerative diseases, has officially launched ZUNVEYL, a new treatment for individuals with mild to moderate Alzheimer’s disease. ...
Imfinzi Approved in EU as First Immunotherapy for Limited-Stage SCLC
AstraZeneca's Imfinzi (durvalumab) has received approval in the European Union (EU) for use as a monotherapy in adults with limited-stage small cell lung cancer (LS-SCLC). The treatment is specifically for patients whose disease has not progressed after undergoing platinum-based chemoradiation therapy (CRT)....
NEXTBIOMEDICAL Receives FDA Breakthrough Device Designation for Nexsphere-F™ Resorbable Microsphere
NEXTBIOMEDICAL has announced that its innovative product, Nexsphere-F™, has received Breakthrough Device Designation from the United States Food and Drug Administration (FDA). Nexsphere-F™ is a resorbable microsphere designed for musculoskeletal pain embolisation....
Stereotaxis Introduces First-of-its-Kind MAGiC Sweep™ a Robotically Navigated Mapping Catheter
Stereotaxis a leading company in surgical robotics for minimally invasive endovascular procedures, has submitted its MAGiC Sweep™ catheter for regulatory approval to the US Food and Drug Administration (FDA)....
Medtronic Receives First-of-Its-Kind Approval for BrainSense™ Adaptive DBS and Electrode Identifier
Medtronic has received FDA approval for its BrainSense™ Adaptive deep brain stimulation (aDBS) and BrainSense™ Electrode Identifier (EI), advancing personalised treatment for Parkinson’s disease. DBS, a key therapy for neurological disorders, has been enhanced with BrainSense...
Atreon Orthopedics Launches First-of-Its-Kind BioCharge® Autobiologic Matrix for Rotator Cuff Repair
Atreon Orthopaedics has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its BioCharge® Autobiologic Matrix. The product is now being launched for full market availability. BioCharge is a bioresorbable synthetic implant designed to improve...
QuantalX Neuroscience Introduces Groundbreaking Delphi-MD Device for Brain Health Assessment in Europe
QuantalX Neuroscience has achieved a significant milestone with the CE MDR approval for its Delphi-MD device, a groundbreaking solution for brain health assessment. This certification, granted under the European Union’s Medical Device Regulation (MDR), establishes high standards for safety...
FDA Grants Onc.AI Breakthrough Device Designation for "Serial CTRS" in Early Mortality Risk Assessment
Onc.AI, a digital health company specialising in AI-driven oncology clinical management solutions, has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Serial CT Response Score (Serial CTRS) AI model....
FDA Approves Roche's First-of-its-Kind Tina-quant® Lipoprotein (a) Gen.2 for measuring Lp(a) in molar units
Roche has announced that its Tina-quant® Lipoprotein (a) Gen.2 Molarity assay has received 510(k) clearance from the United States Food and Drug Administration (FDA)....
